We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dianon Announces Acquisition of UroCor

By Labmedica staff writers
Posted on 20 Nov 2001
In a move to expand its line of cancer diagnostics, Dianon Systems, Inc. More...
(Stratford, CT, USA) has acquired UroCor, Inc. (Oklahoma City, USA) in a stock-for-stock transaction. Dianon provides a full line of anatomic and molecular pathology testing services.

UroCor markets a wide range of products for detecting, diagnosing, and treating prostate cancer, bladder cancer, kidney stones, and other urologic disorders. The company provides diagnostic services to detect major urologic conditions, enhance the accuracy of prognosis, monitor therapy, and identify recurrence.

"This acquisition represents a significant step in our mission to become the leader in cancer diagnostics through expert pathology, clinical, and genomic services,” said Kevin C. Johnson, chairman, president, and CEO of Dianon Systems.





Related Links:
UroCor
Dianon

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Immunofluorescence Analyzer
IFA System
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.